Classification et morbidités des chirurgies de résection dans les cancers de l’ovaireClassification and morbidity of debulking surgery for advanced ovarian cancer

Postoperative residual disease is a major predicting factor in the treatment of advanced ovarian cancer. The goal of the surgery is now well known. It is to eradicate all macroscopic tumor. So, the most useful way to describe the residual disease is to measure exactly the size of the tumor left after surgery (no gross residual, gross residual 10 mm) and to avoid the usual classification (optimal and suboptimal). The goal of no gross residual disease after surgery involves more often extended surgical efforts particulary upper abdominal surgery (diaphragm stripping, splenectomy, etc.). Radical procedures without any macroscopic residual disease have been shown to be safe and potentially beneficial to patients.